{"id":92306,"topic":"peptides","source":"东方财富","title":"泰德医药：完成收购杭州一处工业用地及房产 拟作多肽定制研发生产基地 - 东方财富","url":"https://wap.eastmoney.com/a/202609243883740831.html","url_hash":"136df41deec982b05b88312d68efef8f17e45bbb","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9yZ0k5T0thY0lKeWJtVFhPY25nY0s3QmpsWUY0MWxBZmVhZnFkYWhiYi1LMDl2TEc1NkRuUFpWYl83dl9oVnFxbjgxVC1tLWMwMU1YOW9QSDJGQThVUDJ4Sg?oc=5\" target=\"_blank\">泰德医药：完成收购杭州一处工业用地及房产 拟作多肽定制研发生产基地</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">东方财富</font>","content":"南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩的规模化定制研发生产园区。\n（文章来源：南方财经网）\n南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩的规模化定制研发生产园区。\n（文章来源：南方财经网）","image_url":"https://g1.dfcfw.com/g4/202112/20211206191716.png","lang":"zh","published_at":"2026-09-24T09:05:48+00:00","fetched_at":"2026-09-29T00:15:12+00:00","status":"read","starred":0,"extract_state":"ok","summary_auto":"南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩…","cluster_id":3499037,"extract_retries":0,"extract_error":null,"contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://wap.eastmoney.com/a/202609243883740831.html","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 493 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":493,"summary_length":221,"usable_text_length":493,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":493,"summary_length":221}},"news_item":{"id":92306,"canonical_url":"https://wap.eastmoney.com/a/202609243883740831.html","source_url":"https://wap.eastmoney.com/a/202609243883740831.html","title":"泰德医药：完成收购杭州一处工业用地及房产 拟作多肽定制研发生产基地 - 东方财富","source_name":"东方财富","author":null,"published_at":"2026-09-24T09:05:48+00:00","locale":"zh","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9yZ0k5T0thY0lKeWJtVFhPY25nY0s3QmpsWUY0MWxBZmVhZnFkYWhiYi1LMDl2TEc1NkRuUFpWYl83dl9oVnFxbjgxVC1tLWMwMU1YOW9QSDJGQThVUDJ4Sg?oc=5\" target=\"_blank\">泰德医药：完成收购杭州一处工业用地及房产 拟作多肽定制研发生产基地</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">东方财富</font>","full_text":"南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩的规模化定制研发生产园区。\n（文章来源：南方财经网）\n南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩的规模化定制研发生产园区。\n（文章来源：南方财经网）","excerpt":"南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩…","extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 493 characters.","diagnostics_url":"/api/diagnose?url=https%3A//wap.eastmoney.com/a/202609243883740831.html","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 493 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":493,"summary_length":221,"usable_text_length":493,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":493,"summary_length":221}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"泰德医药：完成收购杭州一处工业用地及房产 拟作多肽定制研发生产基地 - 东方财富","url":"https://wap.eastmoney.com/a/202609243883740831.html","summary":"南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩…","source":"东方财富","date":"2026-09-24T09:05:48+00:00","content":"南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩的规模化定制研发生产园区。\n（文章来源：南方财经网）\n南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩的规模化定制研发生产园区。\n（文章来源：南方财经网）","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//wap.eastmoney.com/a/202609243883740831.html","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 493 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 493 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":493,"summary_length":221,"usable_text_length":493,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":493,"summary_length":221}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/92306","export_markdown":"/api/items/92306/export?format=markdown","export_json":"/api/items/92306/export?format=json","diagnose":"/api/diagnose?url=https%3A//wap.eastmoney.com/a/202609243883740831.html"},"formats":{"full":{"id":92306,"title":"泰德医药：完成收购杭州一处工业用地及房产 拟作多肽定制研发生产基地 - 东方财富","url":"https://wap.eastmoney.com/a/202609243883740831.html","source":"东方财富","author":null,"published_at":"2026-09-24T09:05:48+00:00","locale":"zh","topic":"peptides","tags":[],"excerpt":"南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩…","full_text":"南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩的规模化定制研发生产园区。\n（文章来源：南方财经网）\n南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩的规模化定制研发生产园区。\n（文章来源：南方财经网）","reading_time_min":1,"extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 493 characters.","diagnostics_url":"/api/diagnose?url=https%3A//wap.eastmoney.com/a/202609243883740831.html","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 493 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":493,"summary_length":221,"usable_text_length":493,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":493,"summary_length":221}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 493 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":493,"summary_length":221,"usable_text_length":493,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":493,"summary_length":221}},"actions":{"read":"/item/92306","export_markdown":"/api/items/92306/export?format=markdown","export_json":"/api/items/92306/export?format=json","diagnose":"/api/diagnose?url=https%3A//wap.eastmoney.com/a/202609243883740831.html"}},"digest":{"id":92306,"title":"泰德医药：完成收购杭州一处工业用地及房产 拟作多肽定制研发生产基地 - 东方财富","url":"https://wap.eastmoney.com/a/202609243883740831.html","source":"东方财富","topic":"peptides","published_at":"2026-09-24T09:05:48+00:00","excerpt":"南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩…","quality_bucket":"high","quality_reason":"High confidence: full text extraction produced 493 characters.","reading_time_min":1,"cluster_id":3499037},"card":{"display_title":"泰德医药：完成收购杭州一处工业用地及房产 拟作多肽定制研发生产基地 - 东方财富","subtitle":"东方财富 · 2026-09-24","summary":"南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩…","badges":["quality:high"],"links":{"read":"/item/92306","original":"https://wap.eastmoney.com/a/202609243883740831.html","diagnose":"/api/diagnose?url=https%3A//wap.eastmoney.com/a/202609243883740831.html"},"quality_warning":null},"export":{"title":"泰德医药：完成收购杭州一处工业用地及房产 拟作多肽定制研发生产基地 - 东方财富","url":"https://wap.eastmoney.com/a/202609243883740831.html","summary":"南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩…","source":"东方财富","date":"2026-09-24T09:05:48+00:00","content":"南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩的规模化定制研发生产园区。\n（文章来源：南方财经网）\n南财智讯9月24日电，泰德医药（03880.HK）发布自愿公告，为推进集团多肽及寡核苷酸定制研发生产业务的产能战略布局，集团已就位于杭州市钱塘区的一处工业用地及房产签署收购协议，截至公告日有关收购已完成，拟将其作为集团规模化定制研发生产基地项目一期。该项目占地面积约30亩，现有厂房建筑面积约13500平方米。集团规划于该项目建规模化多肽原料药生产线，规划设计年产能预计3-5吨。后续集团拟进一步整合二期毗邻约56亩地块，打造总占地约86亩的规模化定制研发生产园区。\n（文章来源：南方财经网）","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//wap.eastmoney.com/a/202609243883740831.html","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 493 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 493 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":493,"summary_length":221,"usable_text_length":493,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":493,"summary_length":221}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}